Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02406105 : An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease
PhasePhase 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Idiopatic Parkinson Disease (PD)

- Lack of effective pharmacotherapy

- Lack of possibilities of qualifications to DBS (deep brain stimulation) procedure

- Informed consent for participation in the study and for radiotherapy

Exclusion Criteria:

- Age under 18

- Pregnancy

- Other than PD induced tremor

- Dementia, psychosis.

- Poor performance status

- Atrophic cerebral changes, structural changes in basal nuclei

- Lack of informed consent.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557